TrialBMC infectious diseases2021

An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.

J Surey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.